Tag:
RG7204
Latest Headlines
Latest Headlines
Roche spotlights top late-stage drug prospects in pipeline review
What's Roche willing to bet hundreds of millions of dollars on next year? This morning the pharma giant answered that question by highlighting its 14 late-stage prospects in the pipeline, promising
Plexxikon, Roche melanoma drug shows promise in trial
Data from a study showed the BRAF inhibitor RG7204 (PLX-4032), which was developed by 2010 Fierce 15 winner Plexxikon and being studied by Genentech ( $DNA ), shrank tumors in more than half of people
